BridgeBio Oncology Therapeutics, Inc. reports

Company location: South San Francisco, CA
Fiscal year end: 31 December

BridgeBio Oncology Therapeutics, Inc. has filed 170 SEC EDGAR filings since 20 Dec 2023

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 1-25 of 170 matching filings.

Per page

25

Current page

1

4

4

Filing date: 06 Jul 2026
Reporting date: 01 Jul 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 06 Jul 2026
Reporting date: 01 Jul 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 06 Jul 2026
Reporting date: 01 Jul 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 06 Jul 2026
Reporting date: 01 Jul 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13D/A File 005-94447

SCHEDULE 13D/A filing

Filing date: 06 Jul 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 06 Jul 2026
Reporting date: 01 Jul 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

424B3 File 333-289940

424B3

Filing date: 22 Jun 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-41955

8-K

Filing date: 22 Jun 2026
Reporting date: 16 Jun 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4

Filing date: 18 Jun 2026
Reporting date: 16 Jun 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 18 Jun 2026
Reporting date: 16 Jun 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 18 Jun 2026
Reporting date: 16 Jun 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 18 Jun 2026
Reporting date: 16 Jun 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 18 Jun 2026
Reporting date: 16 Jun 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 18 Jun 2026
Reporting date: 16 Jun 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 18 Jun 2026
Reporting date: 16 Jun 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

424B3 File 333-289940

424B3

Filing date: 13 May 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-41955

10-Q

Filing date: 12 May 2026
Reporting date: 31 Mar 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-41955

8-K

Filing date: 12 May 2026
Reporting date: 12 May 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4

Filing date: 12 May 2026
Reporting date: 10 May 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 12 May 2026
Reporting date: 10 May 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

424B3 File 333-289940

424B3

Filing date: 06 May 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 05 May 2026
Reporting date: 01 Apr 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 05 May 2026
Reporting date: 01 Apr 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 05 May 2026
Reporting date: 01 Apr 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-289940

EFFECT filing

Filing date: 04 May 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .